More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested.

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...